Basel Medical (BMGL) Liabilities and Shareholders Equity (2024 - 2025)
Basel Medical recorded quarterly Liabilities and Shareholders Equity of $14.4 million in Q2 2025, up 27.83% quarter-over-quarter from $11.2 million in Q4 2024, and up 19.05% year-over-year from $12.1 million in Q2 2024.
Basel Medical's Liabilities and Shareholders Equity history runs 2 years deep, the most recent figure standing at $14.4 million for Q2 2025.
- In Q2 2025, Liabilities and Shareholders Equity rose 19.05% year-over-year to $14.4 million; the TTM figure through Jun 2025 stood at $37.6 million (changed N/A YoY), while the FY2025 annual figure was $14.4 million, up 19.05% from the prior year.
- Liabilities and Shareholders Equity came in at $14.4 million for Q2 2025 at Basel Medical, up from $11.2 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $14.4 million in Q2 2025 to a low of $11.2 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn | 61.45 Bn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn | 31.20 Bn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn | 17.50 Bn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn | 7.31 Bn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn | 5.61 Bn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn | 15.68 Bn |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn | 36.09 Bn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn | 1.54 Bn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn | 5.66 Bn |
| 10 | Basel Medical | 8.57 Mn | 6.23 Mn | - | 14.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 14.35 Mn |
| Dec 31, 2024 | 11.23 Mn |
| Jun 30, 2024 | 12.05 Mn |